Back

UK Salivary Gland Cancer Research Working Group

Share this article

Prior to its closure, the NCRI Head and Neck Group published its strategic priorities for Head and Neck Cancer Research across the UK. This working group was tasked 'to identify the gaps in Salivary Gland Cancer Research and develop strategic priorities for this area of research'. SGC UK will be continuing the planned activity and are delighted to be inviting applicants to the working group.

Click on the titles to access the Role Description and Terms of Reference for the working group.

We are now working on the follow ups post our inaugural meeting on March 8th 2024. Make sure you're signed up to stay updated.

 

 

 

To apply, please provide the following by Monday January 15th 2024 at 5pm to [email protected].
Please note: The initial one day workshop to agree the priorities for SGC research on Friday March 8th 2024 in Manchester. 

  • Title
  • Name
  • Organisation
  • Job Title
  • Please provide a short biography (max. 150 words)   
  • Please briefly state why you are interested in being a part of this working group and how your skills and expertise would be beneficial to the project. (max 300 words)   
  • Please attach a CV (max 2 pages)
  • Are you able to attend on Friday March 8th 2024? (this date has moved from March 22nd to allow for conflicts with a European conference)

All workstream updates will be posted via our mailing list so please do sign up (even if you are not applying to be part of the workstream) here: https://confirmsubscription.com/h/j/0A9A5C05BBFE37AA  

Please do share with your networks and don't hesitate to reach out with any questions to [email protected].  You can also share the opportunity via LinkedIn:  https://www.linkedin.com/feed/update/urn:li:activity:7135198184493993984

Please note we are seeking input from ALL stakeholders.  

Size and Composition of the working group:
There is no limit to the number of people who can join a Working Group, however it is important that each member has an active role within the Working Group. Each Working Group must include:
• Chair and co-Chair (of a complimentary skill set to the Chair).
• Early Career Researcher (ECR) lead.
• At least two patients, carers or persons affected by cancer.
• A broad mix of clinicians, basic scientists, allied health professionals, nurses, pathologists and others with relevant professional expertise, as required.

Timeline for recruitment:

- Monday 15th January 2024 - Application window closes
- Wc Monday 29th January - Notification of Working Group appointments
- Friday March 8th 2024 in Manchester, UK one day workshop scheduled to agree the priorities for SGC research.
- Regular meeting series to be set up - every 8-12 weeks

Existing Working Group members:

Co-Chairs: Emma Kinloch and Dr Robert Metcalf
Deputy Chair: Professor Ali Khurram
Early Career Researcher (ECR): Dr Will Ince

Professor Ali Khurram

Ali Khurram is a Professor and Consultant Pathologist at the University of Sheffield.

He specialises in salivary gland diagnosis and receives referrals and second opinion cases from across the world. He has a special interest in diagnostic, prognostic and therapeutic markers in head and neck and salivary cancers.

His research interests include application of digital pathology, artificial intelligence and investigating the genomic landscape of these cancers for early detection and to reveal new disease markers for better patient stratification and is leading multiple multicentre collaborative research studies.

He is passionate about raising the profile of these cancers and works closely with patient groups and charities. He is also the Secretary for the British Society for Oral and Maxillofacial Pathology (BSOMP), Digital Adviser for the Pathological Society for Great Britain and Ireland (PathSoc) and a Patron of the Swallows Head and Neck Cancer charity.


Dr Will Ince

look after patients with head and neck cancers and have a particular interest in metastatic salivary gland cancers.

I use the full breadth of non-surgical oncology treatments, with particular interests in clinical trials, novel biomarkers and immunotherapy. I am in the process of setting up a regional referral centre/clinic for patients with advanced salivary gland cancer with a particular focus on research both translational, with scientific colleagues at the University of Cambridge, and both industry and investigator initiated clinical trials.  

I am principal investigator for multiple national and international clinical trials. I am the research network lead for kidney and bladder cancer and have co-authored national guidance in urological malignancies. I work closely with charities and patient advocacy groups and have co-authored leaflets for Prostate Cancer UK and Kidney Cancer UK.

I have small children and Labradors which keep me busy when I am not working.